Top Markets
Coin of the day
Solasia Pharma K.K. Solasia Pharma K.K.

Solasia Pharma K.K.

4597
Clasificación en acciones #24755
Established in 2006 and headquartered in Tokyo, Japan, Solasia Pharma K.K. is... Established in 2006 and headquartered in Tokyo, Japan, Solasia Pharma K.K. is dedicated to the development and commercialization of oncology treatments throughout Japan and other parts of Asia. The company's marketed products include SP-03 (episil oral liquid), designed for the protection and relief of oral pain and inflammation (mucositis/stomatitis) resulting from cancer chemotherapy and radiation. Additionally, they offer SP-01 (Sancuso), a transdermal patch that delivers granisetron, an anti-emetic, into the bloodstream to manage chemotherapy-induced nausea and vomiting. Solasia Pharma's development pipeline features SP-02 (Darinaparsin), a mitochondrial-targeted agent that has successfully completed Phase III clinical trials for a range of hematologic and solid cancers. Also in Phase III clinical study is SP-05 (Arfolitixorin), which aims to bolster the anti-tumor effectiveness of fluorouracil in various cancers, including pancreatic, breast, stomach, and head and neck cancers. In its pre-clinical stage, SP-04 is being developed to address chemotherapy-induced peripheral neuropathy.
Precio por acción
$0.20877985
Capitalización bursátil
$57.00M
Cambio (1 día)
-11.11%
Cambio (1 año)
-20.59%
País
JP
Comercio Solasia Pharma K.K. (4597)

Categoría

Historial del precio de la acción de Solasia Pharma K.K. (4597)
Precio más alto de cierre: $0.21 el 2026-08-01

Precio más bajo de cierre: $2.17 el 2017-03-01
Historial del precio de la acción de Solasia Pharma K.K. desde 2017 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 1.92%
2025 -28.32%
2024 -29.74%
2023 6.85%
2022 -59.89%
2021 -29.23%
2020 -20.28%
2019 12.42%
2018 -61.95%
2017 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$171.67 -
DE
$162.92 26.96%
DE
$37.61 23.06%
JP
$221.10 30.97%
CH
$20.99 11.74%
IN